Neoplasms: all 9,617 studies
Page 64 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.
- A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLLActive, not recruitingNCT03467867Phase 2
- Individual Approach in Gynecological Cancer BrachytherapyActive, not recruitingNCT03466957Not applicable
- Study to Evaluate the Safety and Anti-tumor Activity of SCC244CompletedNCT03466268Phase 1
- A Phase I Study of MSB2311 in Advanced Solid TumorsCompletedNCT03463473Phase 1
- Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantActive, not recruitingNCT03459170Phase 1
- Pre-Operative Single Shot Rectus Sheath BlockCompletedNCT03458598Not applicable
- A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid TumorsCompletedNCT03457532Phase 1
- Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT03454243Early Phase 1
- Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint InhibitionCompletedNCT03453892
- Investigation of PSMA PET/CT as an Imaging Biomarker in Solid TumorsCompletedNCT03453528Not applicable
- This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)CompletedNCT03449381Phase 1
- A Study of PTS for Patients With Solid TumorsWithdrawnNCT03448211Phase 1
- Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young AdultsCompletedNCT03445858Early Phase 1
- Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With CancerCompletedNCT03445572Not applicable
- Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal MalignanciesCompletedNCT03443674Phase 1
- Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid TumorsWithdrawnNCT03443622Phase 1
- Extended Access of Momelotinib in Adults With MyelofibrosisActive, not recruitingNCT03441113Phase 2
- Local Hyperthermia for the Treatment of Cervical Intraepithelial NeoplasiasCompletedNCT03436251Not applicable
- Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic NeoplasmsStatus unknownNCT03435770Not applicable
- Multi Parametric Test Predicting the Risk of Colorectal Neoplasia RecurrenceStatus unknownNCT03434925Not applicable
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
- OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaCompletedNCT03429816Not applicable
- First-in-human Study of Oral TP-0184 in Patients With Advanced Solid TumorsCompletedNCT03429218Phase 1
- Normal Saline Vrs Balanced i.v. Fluids in NeurosurgeryStatus unknownNCT03429127
- Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer.CompletedNCT03428529Phase 2/3
- Imaging of Advanced Tumours Using [131]I-IAZAWithdrawnNCT03427320Phase 1/2
- CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaCompletedNCT03425279Phase 1/2
- Longitudinal Identity Study of Childhood Cancer SurvivorsCompletedNCT03424343
- Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer.Status unknownNCT03423056Not applicable
- Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent IbrutinibActive, not recruitingNCT03422393Phase 1
- AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerCompletedNCT03421353Phase 1
- A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell CancerCompletedNCT03416244Phase 2
- Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid TumorsStatus unknownNCT03415659Phase 1
- A Study of ASN007 in Patients With Advanced Solid TumorsCompletedNCT03415126Phase 1
- Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid TumoursStatus unknownNCT03415100Phase 1
- Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic LeukemiaCompletedNCT03415035
- A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 AbnormalitiesTerminatedNCT03410927Phase 1
- Biomarkers of Immune-Related ToxicityActive, not recruitingNCT03409016
- Apatinib With Pembrolizumab in Previously Treated Advanced MalignanciesTerminatedNCT03407976Phase 1
- Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.CompletedNCT03406650Phase 2
- Assess the Safety and Activity of Combined MG005 and Sorafenib (NEXAVAR®) Treatment With Solid TumorCompletedNCT03406364Phase 1
- Risk of Malignancy Index and Assiut Scoring Model for Adnexal MalignancyCompletedNCT03404687
- Avelumab in Refractory Testicular Germ Cell Cancer.CompletedNCT03403777Phase 2
- Carbon Ion Radiation Therapy for Locally Advanced Pancreatic CancerCompletedNCT03403049Phase 1
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic FailureCompletedNCT03399149
- Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid TumorsStatus unknownNCT03398720Phase 1
- Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid MalignanciesCompletedNCT03394144Phase 1
- A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal CancerStatus unknownNCT03392220Not applicable
- A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer CenterCompletedNCT03390283
- Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™CompletedNCT03390127Not applicable
- Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLCStatus unknownNCT03389256Phase 2
- Predictors for Bronchoalveolar Lavage (BAL) Recovery Rate Derived From Quantified Computed Tomography (qCT)CompletedNCT03388580
- TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid TumorsTerminatedNCT03387917Phase 1
- A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid TumorsCompletedNCT03386942Phase 1
- APG-1387 in Patients With Advanced Solid Tumors or Hematologic MalignanciesCompletedNCT03386526Phase 1
- The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.CompletedNCT03384511Phase 4
- Gut Microbiota Prediction of Metachronous Colorectal NeoplasmsStatus unknownNCT03383159
- Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerActive, not recruitingNCT03383094Phase 2
- Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsTerminatedNCT03382977Phase 1/2
- IMX-110 in Patients With Advanced Solid TumorsActive, not recruitingNCT03382340Phase 1/2
- Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant TransformationStatus unknownNCT03381053
- Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast CancerActive, not recruitingNCT03379428Phase 1/2
- Debulking Surgery in Ovarian CancerCompletedNCT03378128Not applicable
- Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/LymphomaStatus unknownNCT03374007Phase 1
- Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)Status unknownNCT03373019Phase 2
- Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian CancerStatus unknownNCT03371693Phase 3
- Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid TumorsActive, not recruitingNCT03364400Phase 1
- Eastern Ablation Registry for Solid Tumor (EAST)Status unknownNCT03362749
- A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid TumorsCompletedNCT03362723Phase 1
- Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With CancerCompletedNCT03360799
- Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid TumorsCompletedNCT03360734Phase 1
- Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial CancerCompletedNCT03359239Phase 1
- Macroscopic Deciduosis in Pregnancy is Finally a Common EntityCompletedNCT03357783
- Cardiac Coherence Combined With Personal Physical Activity in Patients With CancerCompletedNCT03356171Not applicable
- A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid TumorsTerminatedNCT03355066Phase 1
- Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in ChildrenCompletedNCT03354741Not applicable
- 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot StudyCompletedNCT03352037Not applicable
- Practices and Organizations Related to Emerging Occupations of Care (EPOCK) Coordination in OncologyCompletedNCT03350776
- Embryonic Ploidy Status in the Oncofertility PopulationCompletedNCT03350230
- Geriatric Oncology Follow-up in the Alpine ValleyStatus unknownNCT03349229
- An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid TumorsCompletedNCT03349073Phase 1
- Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer STARTCompletedNCT03348722
- Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide PolymorphismsActive, not recruitingNCT03348670Phase 2/3
- Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With CancerWithdrawnNCT03348137
- A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy SubjectsCompletedNCT03346837Phase 1
- Safety and Efficacy Evaluation of IM19 CellsStatus unknownNCT03344705Phase 1
- Safety, Feasibility and Metabolic Effects of the Fasting Mimicking Diet (FMD) in Cancer PatientsCompletedNCT03340935Not applicable
- Intelligent Electric Bicycle for Health (VELIS) to Optimize the Return to Physical Activity for Oncology PatientsCompletedNCT03340857Not applicable
- Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary TumorsCompletedNCT03340844Not applicable
- Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer PatientsTerminatedNCT03339622Phase 3
- A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma MalignanciesWithdrawnNCT03338881Phase 1
- Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.TerminatedNCT03335059Phase 3
- A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid MalignanciesTerminatedNCT03333031Phase 1
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2TerminatedNCT03332355Phase 1
- Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
- Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic MalignanciesCompletedNCT03328494Phase 1
- Augmented Reality Headset as Adjunct Display Monitor in AMIGOWithdrawnNCT03328416Not applicable
- Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine TumoursTerminatedNCT03328065